Sopharma AD Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Ognian Donev
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | 23.6yrs |
Participación del CEO | 8.1% |
Permanencia media de la dirección | sin datos |
Promedio de permanencia en la Junta Directiva | 9.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Sopharma AD (BUL:SFA) Has A Somewhat Strained Balance Sheet
Apr 09Here's Why We Think Sopharma AD (BUL:3JR) Is Well Worth Watching
Feb 20How Many Sopharma AD (BUL:3JR) Shares Do Institutions Own?
Feb 05Should You Rely On Sopharma AD's (BUL:3JR) Earnings Growth?
Jan 22Sopharma AD (BUL:3JR) Has A Somewhat Strained Balance Sheet
Jan 06Sopharma AD (BUL:3JR) Share Prices Have Dropped 25% In The Last Three Years
Dec 22Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Dec 07Are Investors Undervaluing Sopharma AD (BUL:3JR) By 29%?
Nov 19Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Jul 07CEO
Ognian Donev (66 yo)
23.6yrs
Permanencia
лв723,162
Compensación
Mr. Ognian Ivanov Donev, D.Sc. (Econ.), Ph D., serves as the Executive Chairman at Sopharma AD and Sopharma Trading AD and also served as Chief Executive Officer since September 2021 until November 2021. M...
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman | 23.6yrs | лв723.16k | 8.09% BGN 80.1m | |
Deputy Chairman | no data | лв173.75k | 0.000090% BGN 891.4 | |
Director | 5.8yrs | лв252.59k | 0.0012% BGN 12.2k | |
Independent Director | 12.9yrs | лв120.00k | 0.24% BGN 2.3m | |
Director | 2.9yrs | sin datos | 0.012% BGN 119.6k |
9.3yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de SFA se considera experimentada (9.3 años de antigüedad promedio).